KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma.

EBioMedicine · 2024-Dec · PMID 39631145

Panel D质量警告待 EXE 对齐验证

Progression-free survival

Fig. 2 Outcomes based on baseline FDG-PET staging, period, and rituximab. Progression-free survival by ITT analysis of IFRT+(R)CVP vs. IFRT arms in the A) late-era and B) early era. C) Progression-free survival in all patients in the TROG99.03 trial based on whether baseline FDG-PET was used as a staging modality and D) FDG-PET staged patients by IIT analysis of IFRT+(R)CVP vs. IFRT arms. E) Progression-free survival, per treatment received, of R–CVP treated patients compared with all non-rituximab containing treatments. F) Progression-free survival, per treatment received, of R–CVP treated patients compared with CVP treated patients.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.50
质量通过否
预期曲线2
实际曲线1
X 范围0 – 208
Y 范围0 – 100

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

匹配 56 行
Curve序号X (norm)Y (norm)X (real)Y (real)X (pixel)Y (pixel)
210.01750.99313.649196.6216601
220.02340.97924.865595.2703613
230.02920.97926.081995.2703623
240.03510.97927.298295.2703633
250.04090.97928.514695.2703643
260.04680.97929.731095.2703653
270.05260.979210.947495.2703663
280.05850.979212.163795.2703673
290.06430.979213.380195.2703683
2100.07020.979214.596595.2703693
2110.07600.979215.812995.2703703
2120.08190.965317.029293.9189715
2130.08770.951418.245692.5676727
2140.09360.951419.462092.5676737
2150.09940.951420.678492.5676747
2160.10530.951421.894792.5676757
2170.11110.951423.111192.5676767
2180.11700.937524.327591.2162779
2190.12280.923625.543989.86497811
2200.12870.923626.760289.86497911
2210.13450.923627.976689.86498011
2220.14040.923629.193089.86498111
2230.14620.923630.409489.86498211
2240.15200.923631.625789.86498311
2250.15790.923632.842189.86498411
2260.16370.923634.058589.86498511
2270.16960.923635.274989.86498611
2280.17540.923636.491289.86498711
2290.18130.923637.707689.86498811
2300.18710.923638.924089.86498911
2310.19300.923640.140489.86499011
2320.19880.923641.356789.86499111
2330.20470.923642.573189.86499211
2340.21050.923643.789589.86499311
2350.21640.923645.005889.86499411
2360.22220.923646.222289.86499511
2370.22810.909747.438688.51359613
2380.23390.895848.655087.16229715
2390.23980.895849.871387.16229815
2400.24560.895851.087787.16229915
2410.25150.895852.304187.162210015
2420.25730.895853.520587.162210115
2430.26320.895854.736887.162210215
2440.26900.895855.953287.162210315
2450.27490.895857.169687.162210415
2460.28070.881958.386085.810810517
2470.28650.868159.602384.459510619
2480.29240.868160.818784.459510719
2490.29820.868162.035184.459510819
2500.30410.868163.251584.459510919
2510.30990.868164.467884.459511019
2520.31580.868165.684284.459511119
2530.32160.868166.900684.459511219
2540.32750.868168.117084.459511319
2550.33330.861169.333383.783811420
2560.33920.840370.549781.756811523
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0quality_warning待验证12026-07-23T18:34:08+00:00